Patents by Inventor E. Richard Moxon

E. Richard Moxon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL SURFACE ANTIGEN
    Publication number: 20130085262
    Abstract: The invention provides a novel surface polypeptide from Neisseria meningitidis as well as nucleic acid and nucleic acid sequence homologues encoding this protein. Pharmaceutical compositions containing the polypeptide and nucleic acids of the invention are also disclosed as well as methods useful in the treatment, prevention and diagnosis of N. meningitidis infection.
    Type: Application
    Filed: September 14, 2011
    Publication date: April 4, 2013
    Applicant: The University of Queensland
    Inventors: Ian Richard Anselm PEAK, Michael Paul Jennings, E. Richard Moxon
  • NOVEL SURFACE ANTIGEN
    Publication number: 20120123093
    Abstract: The invention provides a novel surface polypeptide from Neisseria meningitidis as well as nucleic acid and nucleic acid sequence homologues encoding this protein. Pharmaceutical compositions containing the polypeptide and nucleic acids of the invention are also disclosed as well as methods useful in the treatment, prevention and diagnosis of N. meningitidis infection.
    Type: Application
    Filed: September 14, 2011
    Publication date: May 17, 2012
    Applicant: The University of Queensland
    Inventors: Ian Richard Anselm PEAK, Michael Paul Jennings, E. Richard Moxon
  • Surface antigen
    Patent number: 8067004
    Abstract: The invention provides a novel surface polypeptide from Neisseria meningitidis as well as nucleic acid and nucleic acid sequence homologues encoding this protein. Pharmaceutical compositions containing the polypeptide and nucleic acids of the invention are also disclosed as well as methods useful in the treatment, prevention and diagnosis of N. meningitidis infection.
    Type: Grant
    Filed: August 11, 2003
    Date of Patent: November 29, 2011
    Assignee: The University of Queensland
    Inventors: Ian Richard Anseim Peak, Michael Paul Jennings, E. Richard Moxon
  • Surface antigen
    Patent number: 8034358
    Abstract: The invention provides a novel surface polypeptide from Neisseria meningitidis as well as nucleic acid and nucleic acid sequence homologues encoding this protein. Pharmaceutical compositions containing the polypeptide and nucleic acids of the invention are also disclosed as well as methods useful in the treatment, prevention and diagnosis of N. meningitidis infection.
    Type: Grant
    Filed: July 12, 2007
    Date of Patent: October 11, 2011
    Assignee: The University of Queesland
    Inventors: Ian Richard Anselm Peak, Michael Paul Jennings, E. Richard Moxon
  • NOVEL SURFACE ANTIGEN
    Publication number: 20100331537
    Abstract: The invention provides a novel surface polypeptide from Neisseria meningitidis as well as nucleic acid and nucleic acid sequence homologues encoding this protein. Pharmaceutical compositions containing the polypeptide and nucleic acids of the invention are also disclosed as well as methods useful in the treatment, prevention and diagnosis of N. meningitidis infection.
    Type: Application
    Filed: July 22, 2010
    Publication date: December 30, 2010
    Applicant: THE UNIVERSITY OF QUEENSLAND
    Inventors: IAN RICHARD ANSELM PEAK, MICHAEL PAUL JENNINGS, E. RICHARD MOXON
  • Vaccine
    Publication number: 20100015175
    Abstract: The invention relates to a vaccine for the treatment of disease caused by Neisseria, the vaccine including one or more immunogenic components for Neisseria serogroups, as well as antibodies to the immunogenic components and methods of preventing and treating Neisseria infections. The immunogens are based on elements of the inner core lipopolysaccharide.
    Type: Application
    Filed: July 24, 2009
    Publication date: January 21, 2010
    Applicant: Isis Innovation Ltd.
    Inventors: Joyce S. Plested, Michael P. Jennings, Margaret Anne Gidney, Andrew D. Cox, James C. Richards, E. Richard Moxon
  • Vaccine
    Publication number: 20100016560
    Abstract: The invention relates to a vaccine for the treatment of disease caused by Neisseria, the vaccine including one or more immunogenic components for Neisseria serogroups, as well as antibodies to the immunogenic components and methods of preventing and treating Neisseria infections. The immunogens are based on elements of the inner core lipopolysaccharide.
    Type: Application
    Filed: July 24, 2009
    Publication date: January 21, 2010
    Applicant: Isis Innovation Ltd.
    Inventors: Joyce S. Plested, Michael P. Jennings, Margaret Ann J. Gidney, Andrew D. Cox, James C. Richards, E. Richard Moxon
  • Vaccine
    Publication number: 20100010211
    Abstract: The invention relates to a vaccine for the treatment of disease caused by Neisseria, the vaccine including one or more immunogenic components for Neisseria serogroups, as well as antibodies to the immunogenic components and methods of preventing and treating Neisseria infections. The immunogens are based on elements of the inner core lipopolysaccharide.
    Type: Application
    Filed: July 24, 2009
    Publication date: January 14, 2010
    Applicant: Isis Innovation Ltd.
    Inventors: Joyce S. Plested, Michael P. Jennings, Margaret Anne Gidney, Andrew D. Cox, James C. Richards, E. Richard Moxon
  • NOVEL SURFACE ANTIGEN
    Publication number: 20090270591
    Abstract: The invention provides a novel surface polypeptide from Neisseria meningitidis as well as nucleic acid and nucleic acid sequence homologues encoding this protein. Pharmaceutical compositions containing the polypeptide and nucleic acids of the invention are also disclosed as well as methods useful in the treatment, prevention and diagnosis of N. meningitidis infection.
    Type: Application
    Filed: July 12, 2007
    Publication date: October 29, 2009
    Inventors: Ian Richard Anselm PEAK, Michael Paul Jennings, E. Richard Moxon
  • Novel surface antigen
    Publication number: 20050058660
    Abstract: The invention provides a novel surface polypeptide from Neisseria meningitidis as well as nucleic acid and nucleic acid sequence homologues encoding this protein. Pharmaceutical compositions containing the polypeptide and nucleic acids of the invention are also disclosed as well as methods useful in the treatment, prevention and diagnosis of N. meningitidis infection.
    Type: Application
    Filed: August 11, 2003
    Publication date: March 17, 2005
    Inventors: Ian Richard Anselm Peak, Michael Paul Jennings, E. Richard Moxon
  • Surface antigen
    Patent number: 6607729
    Abstract: The invention provides a novel surface polypeptide from Neisseria meningitidis as well as nucleic acid and nucleic acid sequence homologues encoding this protein. Pharmaceutical compositions containing the polypeptide and nucleic acids of the invention are also disclosed as well as methods useful in the treatment, prevention and diagnosis of N. meningitidis infection.
    Type: Grant
    Filed: March 5, 2001
    Date of Patent: August 19, 2003
    Assignee: The University of Queensland
    Inventors: Ian Richard Anselm Peak, Michael Paul Jennings, E. Richard Moxon
  • Surface antigen
    Patent number: 6495345
    Abstract: The invention provides a novel surface polypeptide from Neisseria meningitidis as well as nucleic acid and nucleic acid sequence homologues encoding this protein. Pharmaceutical compositions containing the polypeptide and nucleic acids of the invention are also disclosed as well as methods useful in the treatment, prevention and diagnosis of N. meningitidis infection.
    Type: Grant
    Filed: September 26, 2000
    Date of Patent: December 17, 2002
    Assignee: The University of Queensland
    Inventors: Ian Richard Anselm Peak, Michael Paul Jennings, E. Richard Moxon
  • Novel surface antigen
    Publication number: 20020102276
    Abstract: The invention provides a novel surface polypeptide from Neisseria meningitidis as well as nucleic acid and nucleic acid sequence homologues encoding this protein. Pharmaceutical compositions containing the polypeptide and nucleic acids of the invention are also disclosed as well as methods useful in the treatment, prevention and diagnosis of N. meningitidis infection.
    Type: Application
    Filed: March 5, 2001
    Publication date: August 1, 2002
    Inventors: Ian Richard Anselm Peak, Michael Paul Jennings, E. Richard Moxon
  • Surface antigen
    Patent number: 6197312
    Abstract: The invention provides a novel surface polypeptide from Neisseria meningitidis as well as nucleic acid and nucleic acid sequence homologues encoding this protein. Pharmaceutical compositions containing the polypeptide and nucleic acids of the invention are also disclosed as well as methods useful in the treatment, prevention and diagnosis of N. meningitidis infection.
    Type: Grant
    Filed: August 19, 1999
    Date of Patent: March 6, 2001
    Assignee: The University of Queensland
    Inventors: Ian Richard Anselm Peak, Michael Paul Jennings, E. Richard Moxon